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Abstract 
Background: Contemporary phenomenological research has considered abnormal 
bodily phenomena (ABP) to be a phenotypic trait of subjects with schizophrenia in 
their first psychotic episode. Yet the prevalence of ABP and their clinical significance 
in subjects at Ultra High Risk (UHR) of psychosis remains unidentified. This study is 
an exploratory investigation of ABP in UHR subjects and matched healthy controls 
(HC) examining their relation to clinical features and basic self-disturbances. 
Methods: A sample of 26 UHR and 14 HC subjects from three prodromal and early 
intervention clinics in South London, West London and Cambridge was assessed with 
the Abnormal Bodily Phenomena questionnaire (ABPq), Comprehensive Assessment 
of At-Risk Mental States (CAARMS), the Positive and Negative Syndrome Scale 
(PANSS), the Social and Occupational Functioning Assessment Scale (SOFAS) and 
the Examination of Anomalous Self Experiences (EASE) checklist.  
Results: In our sample ABP occurred in 73.1% of UHR subjects and prominent ABP 
(proABP) were referred in 53.8% of them. No HC subject reported ABP. The UHR 
group with proABP had lower CAARMS total score (t=-9.265, p=0.006). There were 
no differences in PANSS total score (t=-1.235, p=0.277), SOFAS score (H(2) 22.27, 
p=0.666) and EASE total scores (z=8.565, adjusted p=0.185) in the UHR subjects 
with prominent ABP versus those that did not.  
Discussion: This initial investigation suggests that ABP could be a prevalent 
phenotypic feature of UHR subjects. 
 
Keywords 
Phenomenology, psychopathology, Ultra High Risk, psychosis, abnormal bodily 
phenomena, anomalous self-experiences 
 
Abbreviations 
Matched healthy control (HC); Ultra High Risk (UHR); Abnormal bodily phenomena 
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Assessment Scale (SOFAS);  
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1. Introduction  
 
Abnormal bodily phenomena (ABP) have been examined in patients with psychosis 
and particularly schizophrenia even in their seminal representations [1]. ABP are 
considered to include several different types of symptoms: disturbed coenesthesia (an 
assortment of uncanny bodily feelings with or without delusional interpretation), 
kinesthetic hallucinations and disruptions of body structure and boundaries. As a 
group, ABP are subjective phenomena that may be quasi-ineffable in nature and until 
recently they have been absent from diagnostic textbooks as we lack sensible, specific 
and reliable tools to assess them. 
 
Following increasing evidence of the limitations of standardized criteria as well as 
fully structured interviews [2] [3], the development of phenomenologically-based, 
semi-structured interviews has allowed a better insight into subjective phenomena [4]. 
This is the case of the EASE interview [5] which focuses on anomalous subjective 
self experiences (ASE), the use of which has become increasingly relevant in research 
on psychosis [6] and schizophrenia [7] [5]. The concept of “self” has brought about 
major interdisciplinary interaction aiming to find common conceptual ground for 
research. One of the present conceptions takes the self as a pyramidal structure with 
three elements: the pre-reflexive (the “basic” experiences which implicitly compose 
one‟s way of being in the world), reflexive (the cognitive appraisal of oneself and the 
world) and narrative (the autobiography which one narrates when portraying oneself). 
The three elements are interlinked in such a way that a disturbance in pre-reflexive 
experience of the self could lead to disturbances of other levels of self experience. 
There are major inputs to this conception from various authors including Joseph 
Parnas, Louis Sass, Dan Zahavi and Shaun Gallagher [7-12]. The “Anomalous self-
experiences” selected by the EASE are an heterogeneous group of phenomena which 
involve symptoms such as: subjectively experiencing a disturbed way of thinking, 
subjectively experiencing a disturbed way of being in the world, subjectively 
experiencing disturbances to one‟s own body, disturbances in interpersonal relations 
and disturbances in principles and attitudes to the world. The EASE interview has 
shown a good internal and external validity and its use in subjects at UHR [13-16] and 
in prodromal phases of schizophrenia [17,18] has shown that ASE are present in these 
populations and suggested they could be used as an early marker.  
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A similar research track has 
now explored the prevalence 
and relevance of ABP in 
patients with first psychotic 
episode and, in particular, in 
subjects with diagnosis of 
schizophrenia [19] [20]. The 
“Abnormal Bodily 
Phenomena Questionnaire” 
(ABPq) [20,21] allows a 
systematized enquiry into 
these experiences. Studies 
using ABPq have shown an 
assortment of bodily 
phenomena occurring in 
schizophrenia [20] and the in 
the first episode psychosis 
[19]. These include uncanny 
feelings of numbness, loss of 
body vitality, the sense of 
disappearance of parts, 
change in form (shrinking or 
enlargement), dimension 
unusual heaviness or 
lightness) or even “movement 
of internal parts” of the body 
[19,22,23]. Examples of these 
phenomena are presented in 
the Box 1.  
 
 
Various studies suggest that 
ABP occur as trait features before the first psychotic episode in patients with 
schizophrenia [24-29]. The Comprehensive Assessment of At-Risk Mental State scale 
Box 1. Example of Abnormal Bodily Phenomena (our 
sample) 
Experience of violation “when he stretched his hand I felt an 
energy entering my body. That energy was pounding my right 
side until it break in” 
Experience of externalization “I felt that my body had become 
as a boiling soup and I was no longer in control of my energy that 
flows around me. Then my body became an ingredient in the 
soup parts of me are the vapors and rest of the soup ” 
Morbid objectivization “I felt my brain freezing. Then thoughts 
were moving so slowly I could feel them drive from ear to ear” 
Devitalization “The loss of the animal part in me, I lost it! I feel 
that I act as I was programmed, even eating and I feel like a 
robot, even my arms feel artificially attached to me” 
Experience of internal dynamization “I felt my brain starting to 
rotate, only slightly, but to a point where I was worried it would 
detach from my neck and it was going to fall to the floor” 
Experience of transformation “I felt that my hands were 
shifting as I moved them towards my face – bigger than smaller. 
Such a scary sense that I had to look away” 
Dysmorphophobia “I always felt my left part of my body was 
not ok. I even wondered that it might not be mine. There is a 
sense of evil from the left side. I feel that it‟s evil” 
Disesthesic paroxysm “blurring feeling on my cheek and neck 
when someone speaks to me. I cannot describe it but its 
sufficiently awkward for me to be scared of being too close” 
Recurrent pain-like experience “the pain just comes and goes… 
normally when I‟m breathing I can end up feeling needles in the 
lung. I know wrong kind of pain as its so different. it doesn‟t help 
taking anything”  
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[31], one of the instruments relevant to the UHR profile, also selects disturbances of 
bodily phenomena. Yet no study has independently regarded their presence and 
clinical significance in subjects at high-risk of psychosis. Therefore their occurrence 
and phenotypic profile is unknown, as is their relation with other presenting 
symptoms.  
 
This study used the ABPq to appraise ABP in a sample of subjects at High Risk of 
Psychosis (HR) and assess their occurrence in this population. Our first goal was to 
measure the prevalence of ABP in UHR group and matched healthy controls (HC). 
Our second goal was to see how the presence of ABP was related to other clinical 
features in this population including (i) functional features (SOFAS), (ii) UHR 
symptoms (PANSS and CAARMS) and (iii) disturbance of basic self-experiences 
(EASE).  
2. Methods  
 
2.1. Setting and sample 
Our sample included subjects at High Clinical Risk for psychosis from OASIS 
(prodromal clinic, SLaM NHS Foundation Trust, London [30]), West London Early 
Intervention and CAMEO (“Cambridge Early Onset”, Cambridge University, 
Cambridge, UK) teams. These clinics are responsible for early intervention in young 
adults where they undertake a detailed multidisciplinary assessment including 
combined review of clinical judgment and screening instruments [30]. We added the 
ABP and EASE semi-structured clinical interviews. Their UHR group is defined by 
High-Risk criteria derived from Comprehensive Assessment of At Risk Mental State 
(CAARMS) [31] and the Social and Occupation Functioning Assessment Scale 
(SOFAS) [32]. Some features of our sample included: subjects were between 18 and 
35 years of age, 65% of our subjects had never used drugs while 12.5% had 
experimented and 15% had moderate to severe use 22.5% were taking antidepressants 
while 7.5% were taking antipsychotics. After an average of 28 months of follow-up 
(November 2015) two of the UHR subjects transitioned to a psychotic episode. 
Enrollment process for controls included advertisement for those matched for age and 
gender subjects and that had no present or past personal or family psychiatric history. 
This study had ethical approval and all the subjects participated after signing a written 
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voluntary informed consent form. 
 
2.2.Procedure: 
In this study, detailed semi-structured interviews were performed by two psychiatrists 
(LM and IB) blind to clinical diagnosis. They have strong training in 
Psychopathology and a course in using the EASE (semi-structured interview similar 
to the Abnormal Bodily Phenomena questionnaire). Joint scoring of audio-recorded 
interviews ensured inter-raters reliability. The final scores were decided through 
consensus discussion. 
 
2.3.Sociodemographics  
In line with previous OASIS studies, socio-demographic data was collected from the 
subjects‟ clinical file. These included age, gender, education, personal or family 
history of psychiatric disorder and present or past psychiatric treatment, country of 
birth and employment (full time students were considered employed). [30]. Healthy 
controls were asked the same questions during the interviews. The sample was 
recruited between August 2013 and November 2013. 
 
2.4.Clinical Measures  
Anomalous Bodily Phenomena Questionnaire (ABPq) [21]  
The prevalence of ABP was assessed with the ABPq, a nine items semi-structured 
interview split into five sections: Demarcation (experience of violation and 
externalisation), Vitality (morbid objectivisation and devitalisation), Coherence 
(experience of internal dynamisation), Identity (experience of transformation and 
dysmorphophobia) and Activity (disesthesic paroxysm and recurrent pain-like 
experiences). Each item is scored for its frequency, intensity, impairment and coping 
in 7 point assessment scale. The developers of ABPq proposed that we should 
acknowledge the overall score as the sum of all scores and the presence of “prominent 
ABP” (proABP) in subjects with scores over 3 in any of the domains. Selected 
examples of patients‟ answers are present in the introduction textbox. 
 
Positive and Negative Syndrome Scale (PANSS) [33]:  
A seven-point assessment of 30 items split into three sections: 7 positive, 7 negative 
and 16 general psychopathology items. It was part of the assessment at admission in 
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the OASIS and CAMEO teams. In our study it allowed the assessment of general 
psychopathology and positive and negative symptoms and their relation to ABP.  
 
Comprehensive Assessment of At-Risk Mental State (CAARMS) [31]  
A semi-structured clinical interview for attenuated psychotic symptoms (thought 
disturbances and perceptual abnormalities), which is part of the assessment of OASIS 
and CAMEO teams. It has 26 items divided across 7 subscales: 4 Positive Symptom 
items, 2 Cognitive and 3 Emotional Disturbances items, 3 Negative Symptoms items, 
4 Behavioral Change items, 4 Motor/Physical Changes items, and 8 General 
Psychopathology items. These are rated on severity and frequency of the symptom in 
a 6-point assessment (from 0 absent/never to 6 psychotic and severe/continuous). 
 
Social and Occupation Functioning Assessment Scale [32]  
This scale is a modified version of the Global Assessment of Functioning (GAF) scale 
separating the measures of social and occupational functioning from the measures of 
symptoms and psychological functioning. Its scores range from 0 to 100. Scoring is 
according to information obtained in the psychiatric interview. 
 
Examination of Anomalous Self Experiences checklist (EASE) [34] 
It is a semi-structured interview for anomalous subjective experience that includes 57 
items (88 if sub-items) and a Cronbach α of 0,87 [6]. It is divided into five subscales 
a) 28 sub-items cognition and stream of consciousness; b) 36 sub-items in self-
awareness and presence; c) 16 sub-items in bodily experiences; d) 6 sub-items in 
demarcation/transitivism; e) 8 sub-items in existential reorientation. Our score was an 
overall dichotomous score in accordance to presence (1) or absence (0) of items. It is 
a reliable instrument to enquire anomalous experiences of the “pre-reflexive” sense of 
first-person perspective or basic self [6]. They have been empirically substantiated in 
a) early psychosis [5], b) prodromal phases of psychosis [13,35] and c) in the 
schizotypic and those with schizotaxia [36]. The abnormalities of self-awareness have 
been shown as promising in the conceptualization of those at risk of psychosis [37] 
and in schizophrenia-prone individuals [16,17]. 
 
2.5.Statistical Analysis 
Descriptive statistics including ANOVA and t-tests for continuous variables and 
Fisher exact test for categorical variables were used to compare between group 
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differences. Non-parametric tests were used as appropriate when the assumptions for 
parametric null hypothesis tests were violated. We tested inter-rater reliability by 
independent reevaluation of the tape recording of the first 6 interviews (three 
interviews performed by IB and three by LM which were subsequently evaluated by 
the other interviewer). 
Our first aim was to measure the prevalence of ABP and proABP in UHR subjects 
and matched HC. Our second aim was to investigate if the presence of proABP 
affected clinical features of UHR including a) UHR symptoms (CAARMS and 
PANSS scores), b) functional status (SOFAS score) and c) disturbance of basic self-
experiences (EASE score). For CAARMS and PANSS scores, as normality 
assumption was maintained, we used t-tests to compare UHRproABP- or 
UHRproABP+ groups. For SOFAS and EASE scores, as the assumption of normality 
and homogeneity of variance were violated (Shapiro-Wilk test significant in at least 
one group for each variable, p<0.05; Levene test significant in every variable but 
EASE Existential Reorientation subscale, p<0.05) we decided to perform Kruskal-
Wallis non-parametric test to compare HC, UHRproABP- and UHRproABP+. For 
post-hoc analysis we used Dunn-Bonferroni‟s approach [38] for multiple comparisons 
in non-parametric test. When not otherwise specified, two-side p<0.05 was considered 
significant. Given the exploratory nature of this study and the small sample size, we 
decided not to control for familywise error rate. Our decision was made to avoid loss 
of statistical power. However, we performed a Bonferroni correction in the post-hoc 
analysis given the large increase in the number of null hypothesis formulated in this 
procedure. The adjusted p-value (p * number of pairwise comparisons) has been 
reported. All the analyses were performed under SPSS IBM 22.  
3. Results  
 
3.1. Sociodemographic characteristics 
Interviews took on average 58 min (SD=10) in HC and 134 min (SD=40) in UHR 
subjects. The inter-rater correlation was 0.90 (p<0.001) overall. The sample 
comprised 26 UHR subjects with mean age of 23.73 years (SD 4.35) and of which 
57% were male. The matching sample of HC participants presented no differences on 
baseline demographics, accounted in Table 1, but the employment rate was higher in 
HC than UHR (Fisher‟s exact test 6.983, p=0.029). 
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3.2. Prevalence of ABP and proABP and average ABPq score  
In our sample, ABP were absent in all subjects in HC group and were found in 19 
(73.1%) UHR subjects where its overall score (mean, SD) was 35.43±35.80. These 
represent subjects with several ABP, which they evaluated in their frequency, 
intensity and impairment and to which they discussed the coping strategies. 
Regarding the individual domain scores, our UHR sample subjects reported (mean, 
SD) a disturbance in ego demarcation score of 4.84±9.76, a disturbance in ego vitality 
score of 9.0±10.47, a disturbance in ego coherence score of 3.00±6.26, a disturbance 
in ego Identity score of 8.05±12.86 and a disturbance in ego activity score of 
10.53±9.36. The scoring system allowed us to identify 14 subjects (53.8%) with 
prominent ABP and hereinafter the acronym UHRproABP+ represents these subjects 
while UHRproABP- represents those that had no ABP or that considered them mild. 
 
3.3. EASE, SOFAS, CAARMS and PANSS scores across HC, UHRproABP+ and 
UHRproABP- groups 
There were statistically significant differences in EASE total and specific scores 
across the three groups of HC, UHRproABP- and UHRproABP+. Table 2 portrays 
EASE and SOFAS scores across HC, UHRproABP- and UHRproABP+ groups. The 
post-hoc analysis between UHRproABP- and UHRproABP+ groups showed no 
differences between their SOFAS score (z=-1.371, p=1.00) and their EASE total score 
(z=8.565, adjusted p=0.185). Figure 1 displays sample distribution of EASE scores 
across HC, UHRproABP- and UHRproABP+ groups. 
In our sample the UHRproABP+ vs UHRproABP- subjects had on average lower 
CAARMS total score (UHRproABP- 41.42±12.32, UHRproABP+ 36.36±24.23, t=-
9.265 (24), p=0.006). There were no statistically significant differences in PANSS 
total score between those groups (UHRproABP-=51.33±12.72, 
UHRproABP+=54.07±17.04, t=-1.235 (24), p=0.277). Table 3 details the differences 
between PANSS and CAARMS specific domain scores across UHRproABP+ and 
UHRproABP- groups. 
4. Discussion  
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This is a preliminary study exploring the prevalence and the impact of ABP on other 
clinical features in UHR subjects. In our sample, ABP were specific and highly 
prevalent in UHR subjects - more than half of the UHR subjects showed prominent 
ABP. There were significant differences in EASE scores across HC, UHRproABP- 
and UHRproABP+. Yet subjects with prominent ABP (versus other UHR subjects) 
only differ in their CAARMS overall score (which was lower) while they did not in 
their EASE total, PANSS and SOFAs scores.  
 
Our first aim was to determine if ABP were present in the UHR subjects. We found 
that 73% of our sample subjects experienced ABP and ~53% experienced prominent 
ABP. This feature contrasted with HC group that reported no ABP. This allowed us to 
speculate that ABP might be a phenotypic marker of psychosis vulnerability, which 
only further studies with larger samples and with clinical control group can show. 
Still, as much as 30% of our sample had no ABP and 50% had no prominent ABP. 
This seems attuned to the fact that the UHR is heterogeneous, presents various 
comorbidities and has diverse diagnostic and functional outcomes [13]. 
 
Our second aim was to determine if ABP impacted on clinical features of the UHR 
population. We found that the presence of proABP status did not differentiate the 
UHR sample across PANSS and SOFAS scores and that proABP subjects had lower 
CAARMS overall score. Again due to the small sample size in our study, the ABP 
value as a clinical feature remains unknown. Yet the lower CAARMS scores made us 
raise the possibility that ABPq might assess phenomena unlike other criteria defining 
UHR for psychosis (including bodily phenomena considered in the CAARMS) as 
50% of our UHR sample had prominent ABP and lower CAARMS score was found.  
 
Our third aim was to test the relation between ABP and anomalous subjective self-
experiences. Our UHR group had higher EASE scores compared to controls. This is 
in line with previous evidence showing the presence of ASE in the UHR group 
[13,14] and the possibility that they segregate the UHR subjects at risk of 
schizophrenia [16]. In our sample we found that subjects referring prominent ABP did 
not have significantly higher EASE scores. This may be due to weak statistical power 
due to small group size in each group and further studies with larger samples are need 
to clarify this issue. It should not be understated that the relation between ABPq and 
EASE interview also occurs at phenomenological level and it is important to elucidate 
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if they are overlapping constructs or if one is a sub-construct of the other. There are 
studies suggesting that ASE lead to ABP [12] while others advocate that ABP 
antecede the occurrence of ASE [39,40]. It seems important to stress that the bodily 
phenomena assessed by the ABPq and the EASE interview are different, for instance, 
the “internal dynamism” phenomenon only appears in the first and the “mirror-
related” phenomenon is only materialized in the second. An overall better 
conceptualization of the mutual implications between ABP and ASE is needed.  
 
4.1 Limitations 
First, due to our small sample size, our study should be considered as an exploratory 
study. We cannot also exclude that our results could be false negatives or false 
positives. The generalization of our results might be limited by the specifics of our 
sample as only two UHR clinics were used. Along these limitations, which are 
specific to our study, it must be considered that the UHR construct has shown 
conceptual and empirical heterogeneity further limiting the relevance of our results to 
other UHR populations [41]. The difference in employment rates across our sample 
groups seemed to be an artefact of the process of selection of the UHR group (the use 
of SOFAS for functioning). A clinical control group (e.g. affective, anxious or 
personality disorders) and follow-up data are necessary to better define the clinical 
relevance of ABP. Lastly, prescribed drugs and illicit substances were appraised and 
yet the small sample size did not allow the determination of their effect on our scores. 
5. Conclusions 
 
This is the first study to explore the prevalence and implications of Abnormal Bodily 
Phenomena in subjects considered at UHR. In our sample ABP were highly prevalent 
(while absent from matched HC) and in 50% of subjects we found prominent ABP. 
We raised the possibility that ABP could be a phenotypic component of UHR 
psychopathology and particularly of a subgroup of these subjects. Future prospective 
and with larger samples studies are necessary before endorsing our considerations and 
particularly, to understand if ABP predicts clinical outcomes or treatment response in 
UHR subjects. 
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Tables and Figures 
Table 1: Socio-demographic and clinical characterization of sample 
 
Total 
sample 
(N=40) 
mean±S
D 
or n (%)  
HC 
(N=14) 
mean±S
D 
or n (%) 
UHR (n = 26) 
 
F or 
Fisher
‟s p 
UHRproAB
P- 
(N=13) 
mean±SD 
or n (%) 
UHRproAB
P+ (N=14) 
mean±SD 
or n (%) 
Age at 
inclusion 
23.9±3.9 
 24.21±3.
22 
23.25±4.07
0 
24.14±4.605 
 
0.227 
p=0.79
8 
Country 
of Birth  
 
   
 
1.107 
p=1.00
0 
United 
Kingdom 
38 (95) 
 
13 (92.9) 12 (100)  13 (92.9) 
 
 
 
Other 2 (5)  1 (7.1) - 1(7.1)   
 
Gender 
 
 
   
 
3.048 
p=0.23
6 
Male 19 (47.5)  4 (28.6) 7 (41.7)  8 (57.1)   
 
Female 21 (52.5)  10 (71.4) 5 (23.8)  6 (42.9)   
 
Ethnicity 
 
 
   
 
1.014 
p=0.70
7 
White 
British 
24 (60) 
 
10 (71.4) 7 (58.3)  7 (53.8) 
 
 
 
Other 15 (37.5)  4 (28.6) 5 (41.7)  6 (46.2)   
 
Missing 1 (2.5)  - -  1 (7.7)   
 
Employe
d/ 
Studying 
 
 
   
 
6.983 
p=0.02
9 
Yes 27 (67.5)  13 (92.9) 8 (66.7)  6 (46.2)   
 
No 12 (30)  1 (7.1) 4 (33.3)  7 (58.3)   
 
Missing 1 (2.5)  - -  1 (7.6)   
 
Mean nº 
years of 
Educatio
n (years) 
14.78±2.
91 
 
16.14±3.
44 
15.08±1.83 13.04±2.33 
 
4.565 
p=0.01
7 
number of subjects or Mean ± SD. Percentages under parenthesis. p-values refer to 
ANOVA and Fisher‟s Exact Test between HC, UHRproABP- and UHRproABP+ 
group for continuous and categorical values respectively 
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Table 2: Between groups differences in EASE and SOFAS scores 
 
 
HC 
(N=14) 
median 
(range) 
Mean rank 
UHRproABP
- 
(N=12) 
median 
(range) 
Mean rank 
UHRproABP
+ 
(N=14) 
median 
(range) 
Mean rank  H(2) p 
EASE score  0.50 (0-9) 
7.68 
20.50 (6-38) 
22.79 
34.00 (18-83) 
31.36 
 
29.570 p<0.001 
EASE 
Cognition and 
Consciousness 
score 
 
0.0 (0-5) 
7.75 
7.00 (2-15) 
23.50 
13.00 (5-23) 
30.68 
 
28.634 p<0.001 
EASE 
Self-awareness 
and Presence 
score 
 
0.00 (0-4) 
7.68 
11.00 (3-19) 
24.50 
13.50 (6-31) 
29.89 
 
28.105 p<0.001 
EASE Bodily 
experiences 
score 
 
0.00 (0-1) 
9.82 
1.50 (0-4) 
20.83 
3.50 (1-15) 
30.89 
 
24.854 p<0.001 
EASE 
Demarcation/ 
transitivism 
score 
 
0.00 (0-0) 
13.50 
0.00 (0-1) 
21.21 
1.00 (0-6) 
26.89 
 
13.121 p=0.001 
EASE 
Existential 
Reorientation 
score 
 
0.00 (0-5) 
12.79 
0.50 (0-7) 
19.33 
4.00 (1-8) 
29.21 
 
15.065 p=0.001 
SOFAS score  91.00 (90-
100) 
30.00 
60.00 (40-75) 
11.70 
59.00 (43-70) 
13.07 
 
22.270 p<0.001 
Three groups were compared and considering the non-normal distribution of data and 
heterogeneity of variance, we adopted the Kruskal–Wallis non-parametric test. 
Median (with range) and mean rank for each group are reported. P values correspond 
to differences between the three groups. Abbreviations: HC: Healthy controls; 
UHRproABP+: UHR subjects with prominent ABP; UHRproABP-: UHR subjects 
with no prominent ABP   
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Table 3: Impact of proABP on the PANSS and CAARMS scores 
 
 
UHRproABP
- 
(N=12) 
mean±SD 
UHRproABP
+ 
(N=14) 
mean±SD 
 t (24) p value 
PANSS Positive Symptoms  12.17±3.90 13.29±4.14  -0.705 p=0.487 
PANSS Negative Symptoms  12.25±4.84 12.07±4.95  0.093 p=0.927 
PANSS General 
Psychopathology 
 26.83±7.15 28.81±9.89  -0.547 p=0.589 
CAARMS Positive 
Symptoms 
 8.83±4.46 7.86±3.48  0.306 p=0.762 
CAARMS Cognitive 
Disturbances 
 3.50±1.93 1.93±1.82  2.111 p=0.045* 
CAARMS Emotional 
Disturbances 
 3.08±2.93 2.93±2.98  0.129 p=0.899 
CAARMS Negative 
symptoms 
 6.25±3.36 4.14±3.35  1.597 p=0.123 
CAARMS Behavioral 
Changes 
 5.58±3.75 5.93±4.92  -0.198 p=0.844 
CAARMS Motor/Physical 
Changes 
 1.17±2.29 2.29±3.99  -0.857 p=0.400 
CAARMS General 
Psychopathology 
 13.50±5.99 11.29±7.80  0.802 p=0.430 
* Significant difference (2-sided p<0.05) 
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Figure 1: Examination of Anomalous Self Experiences Scores in HC, 
UHRproABP- and UHRproABP+ 
The three groups differed for total EASE score (N=40, H(2)=29.570, p<0.001) 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
References 
 
[1] Jaspers K. General Psychopathology 7th Ed. Manchester: Manchester 
University Press; 1963. 
[2] Nordgaard J, Revsbech R, Sæbye D, Parnas J. Assessing the diagnostic 
validity of a structured psychiatric interview in a first-admission hospital 
sample. World Psychiatry 2012;11: 2051-5545. 
[3] Nordgaard J, Sass LA, Parnas J. The psychiatric interview: validity, structure, 
and subjectivity. Eur Arch Psychiatry Clin Neurosci 2013;263:353–64. 
[4] Parnas J, Sass LA, Zahavi D. Recent developments in philosophy of 
psychopathology. Curr Opin Psychiatry 2008;21:578–84. 
[5] Parnas J, Handest P, Jansson L, Sæbye D. Anomalous subjective experience 
among first-admitted schizophrenia spectrum patients: empirical 
investigation. Psychopathology 2005;38:259–67. 
[6] Møller P, Haug E, Raballo A, Parnas J, Melle I. Examination of anomalous 
self-experience in first-episode psychosis: interrater reliability. 
Psychopathology 2011;44:386–90.  
[7] Sass LA, Parnas J. Schizophrenia, consciousness, and the self. SchizopUHR 
Bull 2003;29:427–44. 
[8] Sass LA. Varieties of self-experience: a comparative phenomenology of 
melancholia, mania, and schizophrenia, Part I. J Conscious Stud 
2013;20:103-30. 
[9] Gallagher S. The Oxford Handbook of the Self. New York: Oxford 
University Press; 2011. 
[10] Zahavi D. Exploring the Self: Philosophical and psychopathological 
perspectives on self-experience. Amsterdam/Philadelphia: John Benjamins 
Publishing; 2000. 
[11] Zahavi D. Self and Other: Exploring Subjectivity, Empathy and Shame. New 
York: Oxford University Press; 2014. 
[12] Kircher T, David A. The Self in Neuroscience and Psychiatry. Cambridge: 
Cambridge University Press; 2003. 
[13] Nelson B, Thompson A, Yung AR. Basic self-disturbance predicts psychosis 
onset in the ultra high risk for psychosis “prodromal” population. 
SchizopUHR Bull 2012;38:1277–87. 
[14] Nelson B, Fornito A, Harrison BJ, Yücel M, Sass LA, Yung AR, et al. A 
disturbed sense of self in the psychosis prodrome: linking phenomenology 
and neurobiology. Neurosci Biobehav Rev 2009;33:807–17. 
[15] Nelson B, Thompson A, Chanen AM, Amminger GP, Yung AR. Is basic self-
disturbance in ultra-high risk for psychosis (“prodromal”) patients associated 
with borderline personality pathology? Early Interv Psychiatry 2013;7:306–
10. 
[16] Nelson B, Thompson A, Yung AR. Not all first-episode psychosis is the 
same: preliminary evidence of greater basic self-disturbance in schizophrenia 
spectrum cases. Early Interv Psychiatry 2013;7:200–4.  
[17] Parnas J. Clinical detection of schizophrenia-prone individuals: critical 
appraisal. Br J Psychiatry Suppl 2005;48:s111–2.  
[18] Nelson B, Thompson A, Yung AR. Basic self-disturbance predicts psychosis 
onset in the ultra high risk for psychosis “prodromal” population. 
SchizopUHR Bull 2012;38:1277–87.  
[19] Stanghellini G, Ballerini M, Fusar-Poli P, Cutting J. Abnormal bodily 
experiences may be a marker of early schizophrenia? Curr Pharm Des 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
2012;18:392–8. 
[20] Stanghellini G, Ballerini M, Blasi S, Mancini M, Presenza S, Raballo A, et al. 
The bodily self: a qualitative study of abnormal bodily phenomena in persons 
with schizophrenia. Compr Psychiatry 2014;55:1703–11. 
[21] Stanghellini G, Ballerini M, Cutting J. Abnormal Bodily Phenomena 
questionnaire. J Psychopathology 2014;20:138–43. 
[22] Ey H. Traite des Hallucinations (2 Vols.) Paris. Masson; 1973. 
[23] Dupré EP. Pathologie de l“imagination et de l”émotivité. Paris: Payot; 1925. 
[24] Hemsley DR. The disruption of the “sense of self” in schizophrenia: potential 
links with disturbances of information processing. Br J Med Psychol 1998;71 
(Pt 2):115–24. 
[25] Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing 
schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 
2001;58:158–64. 
[26] Röhricht F, Priebe S. Do cenesthesias and body image aberration characterize 
a subgroup in schizophrenia? Acta Psychiatrica Scandinavica 2002;105:276–
82. 
[27] Stanghellini G. Psicopatologia del senso comune. Milano: Oxford University 
Press; 2009. 
[28] Schultze-Lutter F, Ruhrmann S, Hoyer C, Klosterkötter J, Leweke FM. The 
initial prodrome of schizophrenia: different duration, different underlying 
deficits? Compr Psychiatry 2007;48:479–88. 
[29] Gallese V, Ferri F. Jaspers, the body, and schizophrenia: the bodily self. 
Psychopathology 2013;46:330–6. 
[30] Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and 
support in south London (OASIS), 2001-2011: ten years of early diagnosis 
and treatment for young individuals at high clinical risk for psychosis. Eur 
Psychiatry 2013;28:315–26. 
[31] Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. 
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk 
Mental States. Aust N Z J Psychiatry 2005;39:964–71. 
[32] Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review 
of measures of social functioning. Am J Psychiatry 1992;149:1148–56. 
[33] Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale 
(PANSS) for schizophrenia. SchizopUHR Bull 1987;13:261–76. 
[34] Parnas J, Møller P, Kircher T, Thalbitzer J, Jansson L, Handest P, et al. 
EASE: Examination of Anomalous Self-Experience. Psychopathology 
2005;38:236–58. 
[35] Parnas J, Jansson L, Sass LA. Self-experience in the prodromal phases of 
schizophrenia: A pilot study of first-admissions Neurol Psychiatry Brain Res. 
1998;6:97-106. 
[36] Raballo A, Parnas J. The silent side of the spectrum: schizotypy and the 
schizotaxic self. SchizopUHR Bull 2011;37:1017–26. 
[37] Nelson B, Yung AR, Bechdolf A, McGorry PD. The phenomenological 
critique and self-disturbance: implications for ultra-high risk (“prodrome”) 
research. SchizopUHR Bull 2008;34:381–92. 
[38] Dunn OJ. Multiple comparisons using rank sums. Technometrics, 1964 
6:241–252. 
[39] Scharfetter C. Ego-psychopathology: the concept and its empirical 
evaluation. Psychol Med 1981;11:273–80. 
[40] Kato S, Ishiguro T. Clinical courses of hypochondriac-cenesthopathic 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
symptoms in schizophrenia. Psychopathology 1997;30:76–82. 
[41] Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, Michel C. “A rose is a 
rose is a rose,” but at-risk criteria differ. Psychopathology 2013;46:75–87.  
 
